The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Proximal Tubule Autophagy Differs in Type 1 and 2 Diabetes
Open accessAbstract
Significance Statement: Studies suggest that autophagy may be protective in kidney diseases, but understanding how the autophagic process is specifically altered in each disorder is important for applying it therapeutically. On the basis of the observation that autophagy in proximal tubule epithelial cells is mainly regulated by insulin, the authors used diabetic mouse models to investigate whether types 1 and 2 diabetic nephropathy differ in autophagic status. They found distinct patterns of autophagic dysregulation involved in the pathophysiology of types 1 and 2 diabetic nephropathy, with autophagy induction suppressed in the type 2 diabetic kidney (even under starvation) and basal autophagic activity enhanced in the type 1 diabetic kidney (even under fed conditions). They also provide evidence that activated autophagy protects the type 1 diabetic kidney, whereas autophagic suppression jeopardizes the kidney in type 2 diabetes. Background: Evidence of a protective role of autophagy in kidney diseases has sparked interest in autophagy as a potential therapeutic strategy. However, understanding how the autophagic process is altered in each disorder is critically important in working toward therapeutic applications. Methods: Using cultured kidney proximal tubule epithelial cells (PTECs) and diabetic mouse models, we investigated how autophagic activity differs in type 1 versus type 2 diabetic nephropathy. We explored nutrient signals regulating starvation-induced autophagy in PTECs and used autophagy-monitoring mice and PTEC-specific autophagy-deficient knockout mice to examine differences in autophagy status and autophagy’s role in PTECs in streptozotocin (STZ)-treated type 1 and db / db type 2 diabetic nephropathy. We also examined the effects of rapamycin (an inhibitor of mammalian target of rapamycin [mTOR]) on vulnerability to ischemia-reperfusion injury. Results: Administering insulin or amino acids, but not glucose, suppressed autophagy by activating mTOR signaling. In db / db mice, autophagy induction was suppressed even under starvation; in STZ-treated mice, autophagy was enhanced even under fed conditions but stagnated under starvation due to lysosomal stress. Using knockout mice with diabetes, we found that, in STZ-treated mice, activated autophagy counteracts mitochondrial damage and fibrosis in the kidneys, whereas in db / db mice, autophagic suppression jeopardizes kidney even in the autophagy-competent state. Rapamycin-induced pharmacologic autophagy produced opposite effects on ischemia-reperfusion injury in STZ-treated and db/db mice. Conclusions: Autophagic activity in PTECs is mainly regulated by insulin. Consequently, autophagic activity differs in types 1 and 2 diabetic nephropathy, which should be considered when developing strategies to treat diabetic nephropathy by modulating autophagy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Autophagy in the proximal tubules seemed to be mainly regulated by insulin, instead of amino acids or glucose, which activated the mTOR pathway.”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [154]
In the citing paper
“Of note, using cultured PTECs and different diabetic mouse models, researchers have suggested that type 1 and type 2 DKD, modelled by STZ injection and the db/db mouse models, respectively, differ in autophagic responses154.”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [154]
In the citing paper
“Notably, pretreatment with rapamycin caused stagnation of autophagy and exaggerated kidney IRI in STZ-injected mice, whereas rapamycin reactivated autophagy and attenuated kidney IRI in db/db mice154.”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [154]
In the citing paper
“Therefore, autophagy was suppressed in db/db mice owing to hyperactive mTOR, whereas high levels of autophagy were induced in STZ-injected mice, which eventually led to lysosomal stress.”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [154]
Citations
Cites
Autophagy: Renovation of Cells and Tissues
Mizushima, N., & Komatsu, M. (2011) · Cell · doi:10.1016/j.cell.2011.10.026 · Cited by 6,418
Antimicrobial Autophagy: A Conserved Innate Immune Response in Drosophila
Moy, R. H., & Cherry, S. (2013) · Journal of Innate Immunity · doi:10.1159/000350326 · Cited by 3,539
Autophagy and the Integrated Stress Response
Kroemer, G., Mariño, G., & Levine, B. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.023 · Cited by 3,506
Bjørkøy, G., Lamark, T., Brech, A., Outzen, H., Perander, M., Øvervatn, A., Stenmark, H., & Johansen, T. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200507002 · Cited by 3,276
Autophagy in Human Health and Disease
Choi, A. M. K., Ryter, S. W., & Levine, B. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1205406 · Cited by 2,583 · cited 2×
“To compare the inhibitory effects of glucose, insulin, or amino acid treatment in cultured PTECs on autophagy, cells were starved in HBSS for 24 hours followed by incubation for 1 hour with (1) low-glucose DMEM (100 mg/dl glucose; Gibco, Grand Island, NY) containing 0.1% FBS, (2) low-glucose DMEM containing 10% FBS, (…”
InfluentialHomeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice.
Komatsu, M., Waguri, S., Koike, M., Sou, Y.-S., Ueno, T., Hara, T., Mizushima, N., Iwata, J.-I., Ezaki, J., Murata, S., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.035 · Cited by 2,124
Mizushima, N., Yamamoto, A., Matsui, M., Yoshimori, T., & Ohsumi, Y. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-09-0704 · Cited by 2,105
Zhao, J., Brault, J. J., Schild, A., Cao, P., Sandri, M., Schiaffino, S., Lecker, S. H., & Goldberg, A. L. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.11.004 · Cited by 1,489
Autophagy gone awry in neurodegenerative diseases
Wong, E., & Cuervo, A. M. (2010) · Nature Neuroscience · doi:10.1038/nn.2575 · Cited by 815
Hartleben, B., Gödel, M., Meyer-Schwesinger, C., Liu, S., Ulrich, T., Köbler, S., Wiech, T., Grahammer, F., Arnold, S. J., Lindenmeyer, M. T., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39492 · Cited by 721
Cited by
Autophagy in kidney homeostasis and disease
Tang, C., Livingston, M. J., Liu, Z., & Dong, Z. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0309-2 · Cited by 496
p53/microRNA-214/ULK1 axis impairs renal tubular autophagy in diabetic kidney disease
Ma, Z., Li, L., Livingston, M. J., Zhang, D., Mi, Q., Zhang, M., Ding, H.-F., Huo, Y., Mei, C., & Dong, Z. (2020) · Journal of Clinical Investigation · doi:10.1172/jci135536 · Cited by 220
“(23) consistently demonstrated autophagy dysfunction in both STZ-induced type 1 and db/db type 2 diabetic mice.”
BackgroundMitochondrial dysfunction in diabetic tubulopathy
Yao, L., Liang, X., Qiao, Y., Chen, B., Wang, P., & Liu, Z. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155195 · Cited by 186
Jiang, N., Zhao, H., Han, Y., Li, L., Xiong, S., Zeng, L., Xiao, Y., Wei, L., Xiong, X., Gao, P., et al. (2020) · Cell Proliferation · doi:10.1111/cpr.12909 · Cited by 156
Packer, M. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020010010 · Cited by 132
Metadata
- Authors
- Sakai, S., Yamamoto, T., Takabatake, Y., Takahashi, A., Namba-Hamano, T., Minami, S., Fujimura, R., Yonishi, H., Matsuda, J., Hesaka, A., Matsui, I., Matsusaka, T., Niimura, F., Yanagita, M., & Isaka, Y.
- Affiliations
- The University of Osaka (JP)
- Department of Nephrology, Osaka University Graduate School of Medicine, Osaka, Japan;
- Institute of Medical Sciences (IN)
- Tokai University (JP)
- Kyoto University (JP)
- Corresponding author
- Takabatake, Yoshitsugu
- ORCID
- Venue
- Journal of the American Society of Nephrology
- Published
- 2019-04-30
- Volume
- 30
- Issue
- 6
- Pages
- 929-945
- ISSN
- 1046-6673 (ISSN-L)
- 1533-3450
- PMC
- PMC6551771
- OpenAlex
- W2942855331
- Cited by
- 96
- References
- 57
- Citations by year
- 2026: 8 · 2025: 10 · 2024: 19 · 2023: 17 · 2022: 12 · 2021: 11 · 2020: 15 · 2019: 3
- FWCI
- 7.80
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of the American Society of Nephrology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (17K16082)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Keywords
- autophagy, diabetic nephropathy, type 1 diabetes, type 2 diabetes, proximal tubular epithelial cells, mTOR signaling, insulin, starvation-induced autophagy, lysosomal stress, mitochondrial damage, renal fibrosis, ischemia-reperfusion injury, rapamycin, streptozotocin-induced diabetes, db/db mice
- MeSH terms
- Amino Acids, Animals, Autophagy, Cells, Cultured, Diabetes Mellitus, Experimental, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diabetic Nephropathies, Epithelial Cells, Insulin, Kidney Tubules, Proximal, Lysosomes, Mice, Inbred C57BL, Sensitivity and Specificity, Streptozocin, Mice, Knockout, Sirolimus, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Proximal Tubule Autophagy Differs in Type 1 and 2 Diabetes. https://app.cochat.ai/papers/10.1681/asn.2018100983
- The paper
- Sakai, S., Yamamoto, T., Takabatake, Y., Takahashi, A., Namba-Hamano, T., Minami, S., Fujimura, R., Yonishi, H., Matsuda, J., Hesaka, A., Matsui, I., Matsusaka, T., Niimura, F., Yanagita, M., & Isaka, Y. (2019). Proximal Tubule Autophagy Differs in Type 1 and 2 Diabetes. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.2018100983
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.